1. 203 MDS CONCEPTUAL FRAMEWORK IDENTIFIES UNMET NEED FOR HMA-UNRESPONSIVE AND TRANSPLANT-INELIGIBLE PATIENTS. Issue 1 (April 2015) Authors: Bentley, T.; Broder, M.; Megaffin, S.; Petrone, M.; McKearn, T.; Kurtin, S.; Cogle, C. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 249 CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY. Issue 1 (April 2015) Authors: Steensma, D.; Abedi, M.; Bejar, R.; Cogle, C.; Foucar, K.; Garcia-Manero, G.; George, T.; Grinblatt, D.; Komrokji, R.; Maciejewski, J.; Pollyea, D.; Roboz, G.; Savona, M.; Scott, B.; Sekeres, M.; Thompson, M.; Sugrue, M.; Swern, A.; Nifenecker, M.; Erba, H. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 76 POPULATION INCIDENCE OF MDS FOLLOWING HYPOMETHYLATING AGENT (HMA) TREATMENT FAILURE: ANALYSIS OF US COMMERCIAL CLAIMS DATA. (April 2015) Authors: Cogle, C.; Kurtin, S.; Bentley, T.; Broder, M.; Chang, E.; Lawrence, M.; McKearn, T.; Megaffin, S.; Petrone, M. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗